BD - Becton, Dickinson and Company

02/07/2025 | Press release | Distributed by Public on 02/07/2025 12:46

BD Medication Management Technology Ranked Best in KLAS for Sixth Consecutive Year

BD honored with category leadership for automated dispensing cabinets and traditional smart pumps

SAN DIEGO, Feb. 7, 2025 / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that for the sixth consecutive year, medication management technology from BD has been named Best in KLAS. The BD Pyxis™ MedStation ES was honored with the 2025 Best in KLAS award for Automated Dispensing Cabinets and the BD Alaris™ Infusion System was honored in the Smart Pumps - Traditional category. This recognition underscores BD's market leadership and dedication to safety and innovation across the entire medication use process.

Presented by KLAS Research, the Best in KLAS awards recognize software and services companies that excel in supporting patient care. These annual rankings are based entirely on feedback from in-depth interviews conducted with thousands of health care professionals.

BD's innovative medication management offerings consistently set industry benchmarks, and recognition in multiple categories of the Best in KLAS Awards reaffirms that BD is the clear category leader for some of the most relied-upon tools and technologies in healthcare. Last year, more than 1.2 million infusions were delivered every day via the BD Alaris™ Infusion System to some of the most critically ill patients. And each day, there are more than 9.8 million transactions on BD Pyxis™ devices.

"At BD, our medication management technology represents the backbone of hospital operations and our solutions empower clinicians to focus more on providing hands-on clinical care and less on time-consuming manual processes," said Connor Bates, worldwide president for Medication Management Solutions at BD. "This recognition from KLAS for two of our flagship products is a powerful validation of the work we do to continuously innovate and the push the boundaries of making medication management safer, simpler and smarter."

To see KLAS performance data on the BD Pyxis™ MedStation ES and BD™ Alaris Infusion System and review comments from BD customers, please visit https://klasresearch.com.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.

Contacts:

Media:

Investors:

Hallie Nicholson

Adam Reiffe

Associate Director, Communications

Sr. Director, Investor Relations

760.201.6604

201.847.6927

[email protected]

[email protected]